Active Ingredient(s):Interferon Beta-1b FDA Approved: * August 14, 2009 Pharm Company: *NOVARTIS PHARMS Category:Multiple Sclerosis
Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile.
1 Mechanism of action
2 Side effects
3.1 Clinically isolated syndrome
3.2 Relapsing-remitting MS
4 Commercial formulations
6 External links
Mechanism of ...
* May have multiple approval dates, manufacturers, or labelers.